Form 4: NYT CFO Sells 13,000 Shares Under 10b5-1 Plan

William Bardeen, Executive Vice President and Chief Financial Officer of The New York Times Company, reported the sale of 13,000 shares of Class A Common Stock.

Summary

• William Bardeen, EVP, Chief Financial Officer of The New York Times Company (NYT), reported a sale of company stock.
• The transaction involved the disposition of 13,000 shares of Class A Common Stock.
• The shares were sold at a price of $79.56 per share.
• Following this transaction, Bardeen beneficially owns 18,681 shares of Class A Common Stock directly.
• The transaction occurred on March 3, 2026, and was filed on March 5, 2026.
• The sale was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can sometimes be perceived negatively, this appears to be a routine transaction, potentially under a 10b5-1 plan, and does not provide significant new information about the company's operational performance or future prospects.

Future Outlook

No forward-looking statements or guidance are provided in this insider transaction report.

Industry Context

StockSavvy.ai notes that insider sales, especially by high-ranking executives like a CFO, are common for various personal financial planning reasons, often executed under pre-arranged 10b5-1 plans to avoid accusations of trading on material non-public information. This transaction does not inherently reflect on broader industry trends in media or publishing.

Stakeholder Impact

• Minor potential impact on shareholders, as an insider sale could be interpreted in various ways, though often it's for personal financial planning and not indicative of company performance.

Key Dates

Recommendation

This Form 4 filing reports a routine insider sale by the CFO, William Bardeen, likely under a pre-arranged 10b5-1 plan. Such transactions are common and typically do not provide new fundamental information about the company's health or future prospects that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

New York Times Company, NYT, William Bardeen, Insider Trading, Form 4, Stock Sale, CFO, Class A Common Stock, 10b5-1 Plan